Yüklüyor......
HCV Replicon Systems: Workhorses of Drug Discovery and Resistance
The development of direct-acting antivirals (DAAs) has revolutionized the state-of-the art treatment of HCV infections, with sustained virologic response rates above 90%. However, viral variants harboring substitutions referred to as resistance-associated substitutions (RASs) may be present in basel...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020-06-01
|
| Seri Bilgileri: | Frontiers in Cellular and Infection Microbiology |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/article/10.3389/fcimb.2020.00325/full |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|